Abbott Laboratories

Latest News

Abbott announces CE Mark approval, expanding use of its Panbio COVID-19 Ag Rapid Test Device to include asymptomatic testing and self-swabbing; nasal swab allows for patients to self-collect samples under supervision of a healthcare worker
Jan. 27, 2021, Abbott Laboratories
Abbott fulfills federal government's order of 150 million home-use BinaxNOW COVID-19 Ag Card rapid test, and is ready to make tens of millions of tests available per month for direct purchase to schools, workplaces, pharmacies and other organizations
Jan. 14, 2021, PR Newswire
Abbott announces FDA Emergency Use Authorization for the company's guided home-use BinaxNOW COVID-19 Ag Card rapid test; company expects to deliver, administer 30 million of the tests in Q1 2021 at a price of US$25 each
Dec. 17, 2020, Abbott Laboratories

Trending Topics

Illnesses/Symptoms/Conditions
Medical Devices
Diagnostic Tests/Monitoring De...
Institutional Use/Professional...
Drug/Device Reviews
Hospital/Clinical Devices
Approved Drugs/Devices
Cardiovascular/Heart Health
Home Use/Self-Care
Treatment Devices

Financial Coverage

10,701 millions US$
2,162 millions US$
2,303 millions US$
26.01%
October 2020
2021-02-24
USA

Related Companies

Abbott Laboratories
Alere Inc.
AstraZeneca AB
Boulder Brands Inc. (formerly ...
Celgene Corp.
Center for Science in the Publ...
Danone SA
Fonterra Co-operative Group Lt...
GlaxoSmithKline PLC
Hindustan Unilever Ltd.

Abbott Laboratories Financial References

ABT - Volume
ABT - Volume
Abbott Laboratories (ABT)
Abbott Laboratories (ABT)
ABT - Shares outstanding
ABT - Shares outstanding
ABT - Market Cap
ABT - Market Cap
ABT - EPS Diluted (TTM)
ABT - EPS Diluted (TTM)
ABT - Gross Income (TTM)
ABT - Gross Income (TTM)
ABT - EBIT (TTM)
ABT - EBIT (TTM)
ABT - Research & Development Expense (TTM
ABT - Research & Development Expense (TTM
ABT - Revenue per Employee (TTM)
ABT - Revenue per Employee (TTM)
ABT - Sales (TTM)
ABT - Sales (TTM)
ABT - Earnings (TTM)
ABT - Earnings (TTM)
ABT - Operating Income (TTM)
ABT - Operating Income (TTM)
ABT - Net Income Applicable to Common (TT
ABT - Net Income Applicable to Common (TT
ABT - Net Income per Employee (TTM)
ABT - Net Income per Employee (TTM)
ABT - EPS - Diluted
ABT - EPS - Diluted
ABT - Net Debt
ABT - Net Debt
ABT - Sales
ABT - Sales
ABT - Operating Income
ABT - Operating Income
ABT - Gross Income
ABT - Gross Income
ABT - Earnings
ABT - Earnings
ABT - Total Capital
ABT - Total Capital
ABT - Free Cash Flow
ABT - Free Cash Flow
ABT - EBIT
ABT - EBIT
ABT - Net Income per Employee
ABT - Net Income per Employee
ABT - Research & Development Expense
ABT - Research & Development Expense
ABT - Net Income Applicable to Common
ABT - Net Income Applicable to Common
ABT - Total Debt
ABT - Total Debt
ABT - Net Income Margin
ABT - Net Income Margin
ABT - Revenue per Employee
ABT - Revenue per Employee
ABT - Cash Flow from Investments
ABT - Cash Flow from Investments
ABT - EBITDA Margin
ABT - EBITDA Margin
ABT - EPS Basic (TTM)
ABT - EPS Basic (TTM)
ABT - Dividends Paid (TTM)
ABT - Dividends Paid (TTM)
ABT - Capital Expenditures (CAPEX)
ABT - Capital Expenditures (CAPEX)
ABT - Cash & Equivalents
ABT - Cash & Equivalents
ABT - Total Liabilities
ABT - Total Liabilities
ABT - Total Assets
ABT - Total Assets
ABT - Gross Income Margin
ABT - Gross Income Margin
ABT - EPS - Basic
ABT - EPS - Basic
ABT - Cash Flow from Financing
ABT - Cash Flow from Financing
ABT - Working Capital
ABT - Working Capital
ABT - EBITDA
ABT - EBITDA
ABT - EBITDA (TTM)
ABT - EBITDA (TTM)
ABT - Total Current Liabilities
ABT - Total Current Liabilities
ABT - Total Equity
ABT - Total Equity
ABT - Dividends Paid
ABT - Dividends Paid
ABT - Cash Ratio
ABT - Cash Ratio
ABT - Total Current Assets
ABT - Total Current Assets
ABT - Cash Flow from Operations
ABT - Cash Flow from Operations
ABT - Debt-to-Equity
ABT - Debt-to-Equity

All content is copyrighted by Industry Intelligence, and the original respective author or source. You may not copy, recirculate, redistrubte or publish the content and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.